Last reviewed · How we verify

Short Course of Quinine Plus a Single Dose of Sulphadoxine-Pyrimethamine for Plasmodium Falciparum Malaria

NCT00167739 Phase 4 COMPLETED

Quinine remains the treatment of choice of hospitalised malaria cases. The long treatment duration of 7 days, and adverse reactions often hamper its adequate use. Reducing the treatment duration by adding sulfadoxine-pyrimethamine may enhance compliance and reduce side effects. The efficacy of a 3-day treatment of quinine plus sulfadoxine-pyrimethamine for the treatment of hospitalised, uncomplicated malaria cases was assessed.

Details

Lead sponsorAlbert Schweitzer Hospital
PhasePhase 4
StatusCOMPLETED
Enrolment50
Start date2003-04
Completion2004-02

Conditions

Interventions

Primary outcomes

Countries

Gabon